These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 19309731

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents.
    Shaw JA, Andrianopoulos N, Duffy S, Walton AS, Clark D, Lew R, Sebastian M, New G, Brennan A, Reid C, Ajani AE, Melbourne Interventional Group.
    Cardiovasc Revasc Med; 2008; 9(4):218-23. PubMed ID: 18928945
    [Abstract] [Full Text] [Related]

  • 3. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.
    Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):874-80. PubMed ID: 19180665
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry.
    Yan BP, Gurvitch R, Duffy SJ, Clark DJ, Sebastian M, New G, Warren R, Lefkovits J, Lew R, Brennan AL, Reid C, Andrianopoulos N, Ajani AE.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):928-36. PubMed ID: 18044763
    [Abstract] [Full Text] [Related]

  • 6. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G, Ramondo A, Napodano M, Favaretto E, Gardin A, Bilato C, Nesseris G, Tarzia V, Cademartiri F, Gerosa G, Iliceto S.
    Catheter Cardiovasc Interv; 2009 Jan 01; 73(1):50-8. PubMed ID: 19089938
    [Abstract] [Full Text] [Related]

  • 7. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, Hu J, Zhang Q, Ding FH.
    J Interv Cardiol; 2007 Feb 01; 20(1):10-6. PubMed ID: 17300391
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.
    J Invasive Cardiol; 2006 Dec 01; 18(12):577-83. PubMed ID: 17197706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
    Tamburino C, Angiolillo DJ, Capranzano P, Dimopoulos K, La Manna A, Barbagallo R, Tagliareni F, Mangiafico S, Guzman LA, Galassi AR, Bass TA.
    Catheter Cardiovasc Interv; 2008 Oct 01; 72(4):448-56. PubMed ID: 18814218
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of outcomes of percutaneous coronary intervention of ostial versus nonostial narrowing of the major epicardial coronary arteries.
    Mavromatis K, Ghazzal Z, Veledar E, Diamandopoulos L, Weintraub WS, Douglas JS, Kalynych AM.
    Am J Cardiol; 2004 Sep 01; 94(5):583-7. PubMed ID: 15342287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.
    Garot P, Lefèvre T, Savage M, Louvard Y, Bamlet WR, Willerson JT, Morice MC, Holmes DR.
    J Am Coll Cardiol; 2005 Aug 16; 46(4):606-12. PubMed ID: 16098423
    [Abstract] [Full Text] [Related]

  • 15. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M, Salarifar M, Zeinali AM, Kassaian SE, Dehkordi MR.
    BMC Cardiovasc Disord; 2007 Mar 04; 7():7. PubMed ID: 17335586
    [Abstract] [Full Text] [Related]

  • 16. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk.
    Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann JT.
    Catheter Cardiovasc Interv; 2008 Mar 01; 71(4):533-8. PubMed ID: 18307224
    [Abstract] [Full Text] [Related]

  • 17. Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
    Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW, DELFT (Drug Eluting stent for LeFT main) Registry.
    J Am Coll Cardiol; 2008 Jun 10; 51(23):2212-9. PubMed ID: 18534266
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G.
    Chin Med J (Engl); 2006 Apr 05; 119(7):544-50. PubMed ID: 16620694
    [Abstract] [Full Text] [Related]

  • 19. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A.
    J Cardiovasc Med (Hagerstown); 2007 Aug 05; 8(8):596-601. PubMed ID: 17667030
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
    Qasim A, Cosgrave J, Latib A, Colombo A.
    Am J Cardiol; 2007 Dec 01; 100(11):1619-24. PubMed ID: 18036358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.